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Nitric OxideDNA Strand Breaks
Abstract
Background: Key steps crucial to the process of tumor progression are genomic instability and escape
from apoptosis. Nitric oxide and its interrelated reactive intermediates (collectively denoted as NOX)
have been implicated in DNA damage and mutational events leading to cancer development, while also
being implicated in the inhibition of apoptosis through S-nitrosation of key apoptotic enzymes. The
purpose of this study was to explore the interrelationship between NOX-mediated DNA strand breaks
(DSBs) and apoptosis in cultured tumor cell lines.
Methods: Two well-characterized cell lines were exposed to increasing concentrations of exogenous
NOX  via donor compounds. Production of NOX  was quantified by the Greiss reaction and
spectrophotometery, and confirmed by nitrotyrosine immunostaining. DSBs were measured by the
alkaline single-cell gel electrophoresis assay (the COMET assay), and correlated with cell viability by the
MTT assay. Apoptosis was analyzed both by TUNEL staining and Annexin V/propidium iodine FACS.
Finally, caspase enzymatic activity was measured using an in-vitro fluorogenic caspase assay.
Results: Increases in DNA strand breaks in our tumor cells, but not in control fibroblasts, correlated with
the concentration as well as rate of release of exogenously administered NOX. This increase in DSBs did
not correlate with an increase in cell death or apoptosis in our tumor cell line. Finally, this lack of apoptosis
was found to correlate with inhibition of caspase activity upon exposure to thiol- but not NONOate-based
NOX donor compounds.
Conclusions: Genotoxicity appears to be highly interrelated with both the concentration and kinetic
delivery of NOX. Moreover, alterations in cell apoptosis can be seen as a consequence of the explicit
mechanisms of NOX delivery. These findings lend credence to the hypothesis that NOX may play an
important role in tumor progression, and underscores potential pitfalls which should be considered when
developing NOX-based chemotherapeutic agents.
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Background
Nitric oxide (NO•) is a ubiquitous nitrogen radical species
that has been found to exert protean influences on physi-
ologic and pathophysiologic processes in a wide variety of
organ systems. Vastly increasing the functional conse-
quences of NO•  production is its interrelationship
between the nitroxyl anion (NO-) and the nitrosonium
cation (NO+) depending upon the redox environment in
which NO• is being produced. Each of these interrelated
redox species demonstrates its own biological conse-
quences. Collectively, nitric oxide biology attributable to
the integrated actions of these three species (referred to as
NOX) demonstrates broad reaching consequences.
It is generally thought that well regulated levels of NOX
production is important to numerous physiologic proc-
esses, while NOX overproduction is increasingly being
implicated in pathophysiologic processes via nitrosative
stress. One molecular mechanism underlying these patho-
physiologic processes is NOX-mediated genomic damage
inducing apoptosis in susceptible cells [1]. This induction
of apoptosis is thought to be dependent upon an intact
p53-pathway in response to genotoxicity [2].
While the field of NOX in cancer biology is a new and
developing area of research, the intricacies of NOX influ-
ence are beginning to be elucidated. We have previously
demonstrated widespread increases in expression of nitric
oxide synthase isoforms within human primary tumors
when compared to surrounding normal tissues [3-6].
Both cancer promotive and cancer protective roles have
been ascribed to NOX. Cancer promoting effects include:
1) the capacity to trigger mutagenesis, 2) enhance growth,
invasion, angiogenesis and metastasis of tumors, 3) select
for increasingly virulent tumor cell clones, and 4) sup-
press the host anti-tumor immune response [7,8]. Cancer
protective actions are manifest in the ability of immune-
mediated NOX production to attenuate tumor cell respira-
tion and DNA synthesis as well as to trigger apoptosis. The
mechanistic basis of these differences remains unknown,
but may be explained by: 1) differences in the relevant lev-
els of NOX-species, 2) the redox environment of NOX pro-
duction, 3) the presence and proximity of downstream
response elements within cells under study, 4) the suscep-
tibility of these NOX targets, 5) as well as the rate of NOX
detoxification.
If DNA repair mechanisms are overwhelmed or are inca-
pable of adequate repair, endogenous cell death is trig-
gered via apoptosis. This "programmed cell death" thus
prevents damaged cells from undergoing replication per-
petuating mutational events. Chronic nitrosative stress is
implicated in inhibiting apoptosis. Potential mechanisms
for this inhibition of apoptosis include the alteration of
protein transcription and translation, or post-transla-
tional control of protein function [9]. NOX can alter pro-
tein function through post-translational modification of
thiol groups via S-nitrosation, a key motif within many
enzymes and structural proteins [10]. One target of this
type of post-translational modulation of apoptotic enzy-
matic activity are the caspases [11].
Thus, nitrosative stress can on one hand induce DNA
damage while inhibiting apoptosis, on the other. This
lends mechanistic support to the hypothesis that chronic
nitrosative stress may be cancer promotive in specific situ-
ations. Based on these data, the purpose of this study was
to investigate whether cultured tumor cells exposed to
exogenously administered nitrosative stress undergo
NOX-mediated DNA damage. Furthermore, we investigate
the relationship between this ongoing DNA damage and
cell death via apoptosis within our cell lines of interest.
Methods
Cell Lines
The human lung adenocarcinoma cell line (A549) and the
control SV40 transformed human fibroblast cell line
(WI38) were obtained from the American Type Culture
Collection (Manassas, VA). A549 was grown in RPMI
media, while WI38 cells were grown in MEM (Gibco, Pais-
ley, UK). All media was supplemented with 10% fetal calf
serum, penicillin, streptomycin, L-glutamine, and fungi-
zone. For various tests, cells were harvested after trypsin-
EDTA treatment, washed with Dulbecco's PBS, and resus-
pended in serumless media.
Chemicals
Cells were incubated with one of four NOX-donor com-
pounds that differed in their mode of donation of NO-
equivalents and their half-lives. Two of these compounds
were NONOate donor compounds [diethylenetriamine-
NONOate (DETA-NONOate, Sigma Chemical Company,
St. Louis, MO) and Spermine-NONOate (Oxis Interna-
tional, Portland, OR)] which donate NO• its pure form
into the aqueous environment. The other two compounds
were thiol-based nitric oxide donors [(±)-S-Nitroso-N-
acetypenicillamine (SNAP) and N-(β-D-Glucopyranosyl)-
N2-acetyl-S-nitroso-D,L-penicillamide) glyco-SNAP (Oxis
International, Portland, OR)], which preferentially
donate NO+-equivalents to other thiols. Additionally,
these donors differed in their stability. Based upon our
spectrophotometric analysis at 37°C and a pH of 7.4,
Spermine-NONOate has t1/2 = 5 hours, DETA-NONOate a
t1/2 ≈ 24 hours, SNAP a t1/2 = 10 hours, and glyco-SNAP a
t1/2 = 28 hours [data not shown]. Furthermore, NONOate-
based donors donate two molar equivalents of NOX per
mole of donor compound, whereas the thiol donors
deliver only one mole of NOX per mole of donor com-
pound. These donor compounds were chosen to assess
whether differences in the concentration, mode, or theJournal of Carcinogenesis 2004, 3:16 http://www.carcinogenesis.com/content/3/1/16
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rate of NOX delivery alter the genotoxicity of this radical
species.
Nitrite Production in Media
Nitric oxide donors were added to media without cells or
to cell supernatants at increasing concentrations from 75
to 600 µM. After 24 hours of incubation the amount of
nitrite produced in the media was assayed by the Greiss
reaction as previously described [12,13]. Briefly, 50 µl of
media was added to 50 µl of 1% sulfanilamide in 2.5%
H3PO4. Then 50 µl of 0.1% napthylethylenediamine
dihydrochloride in 2.5% H3PO4 was added in a 96-well
microtiter plate. After incubation at room temperature for
30 minutes, the absorbance was measured on a micro-
plate reader (Molecular Devices, Sunnyvale, CA) at 540
nm. The concentration of nitrite in the media was quanti-
fied as derived from standard curves created by adding
known concentrations of NaNO2 from 50 to 300 µM
sodium nitrite. NOX delivery kinetics was confirmed by
determining changes in λ maximum of each compound
over time on a spectrophotometer (Beckman Coulter
DU530, Fullerton, CA).
Single Cell Gel Electrophoresis (COMET assay)
The COMET assay was performed according to the proce-
dure of Singh et al. with a few modifications [14]. Briefly,
120 µl of 0.5% normal melting point agarose in Ca+2 and
Mg+2-free phosphate buffer at 56°C were quickly layered
onto a fully frosted slide and immediately covered with a
cover-slip. The slides were kept at 4°C to allow the agarose
to solidify. After gently removing the cover-slip a 50 µl
aliquot of cell suspension was mixed with an equal vol-
ume of 1% low melting point agarose (Sigma, St. Louis,
MO) at 37°C and quickly pipetted onto the first agarose
layer in the same manner. Finally, 70 µl of 0.5% LMP aga-
rose was added to cover the cell layer. The slide sand-
wiches without cover-slips were immersed in freshly
prepared, cold lysing buffer [2.5 mol/l NaCl, 100 mmol/l
Na2EDTA, 10 mmol/l Tris, 1% N-Lauroyl sarcosine
sodium salt, pH 10, with 1% Triton X-100 added just
before use] and kept at 4°C for 45 min to 1 hour.
The slides were placed on a horizontal gel electrophoresis
platform and covered with cold alkaline buffer [300
mmol/l NaOH, and 1 mmol/l Na2EDTA] for 8 to 20 min-
utes in the dark at 4°C to allow DNA unwinding and
expression of the alkali-labile sites. The timing for lysis
and unwinding was determined empirically for each cell
line. Electrophoresis was conducted at 4°C in the dark for
20 min at 25 V and 300 mA. The slides were then rinsed
gently twice with neutralizing buffer (0.4 mol/l Tris, pH
7.5). Each slide was stained with 120 µl of propidium
iodine (Sigma) at a concentration of 5 µg/ml and covered
with a cover-slip.
COMET tail lengths were quantified as the distance from
the centrum of the cell nucleus to the tip of the tail in pixel
units, with the mean tail length being determined as the
mean length of twelve tails.
TUNEL Assay for Apoptosis
A terminal deoxynucleotidyl transferase (TdT)-mediated
dUTP labeling (TUNEL) method was used for the detec-
tion of apoptotic cell death. For this purpose, the Apop
Tag-Plus in-Situ Apoptosis Detection Kit (peroxidase)
(Oncor, Gaithersburg, MD) was used. The staining was
performed according to the manufacturer's recommended
procedure. In brief, cell cultures of unexposed or exposed
cells were initially treated with proteinase K (20 µg/ml)
for 15 minutes at room temperature prior to using TdT to
label the 3'-OH ends of DNA with digoxigenin-labeled
nucleotides (1 hour incubation at 37°C). The slides were
then treated with anti-digoxigenin antibody-peroxidase
conjugate for 30 minutes at room temperature, stained
with 3'-3 diaminobenzidine tetrahydrochloride (DAB) for
5 minutes to produce the characteristic brown color of
positive cells, counterstained with hematoxylin, and
mounted. Sections included in the kit were stained and
served as positive controls. Consecutive oil immersion
(100× objective) fields were counted on an Olympus
BX40 microscope. A minimum of 1000 cells were counted
and the apoptotic index was calculated as the percentage
of staining cells. Cells were defined as apoptotic when the
whole nuclear area was labeled or when occasional
labeled globular bodies (apoptotic bodies) could be
observed in the cytoplasm. Apoptosis found in the
untreated cell cytospins at this time point were found to
be 1%. Negative controls were cytospins of our cell lines
in their logarithmic phase of growth supplemented with
conditioned media and FCS. No apoptotic cells were dem-
onstrated in these cytospins.
Annexin V-FITC/propidium iodine FACS
Flow cytometric determination of apoptosis was per-
formed using a commercially available (R&D Systems,
Minneapolis, MN) Annexin V-FITC/propidium iodine
apoptosis detection kit. Untreated and treated cells were
collected after 24 hours of incubation by trypsinization
and centrifugation at 500 × g for 5–10 minutes at room
temperature. Cells were washed and resuspended in ice
cold PBS and pelleted by centrifugation. Cells were then
resuspended in Annexin V incubation reagent at a concen-
tration of 1 × 106 cells/100 µl, and incubated in the dark
for 15 minutes at room temperature. Binding buffer was
then added to each sample. Samples were then analyzed
within one hour by flow cytometry, and evaluated based
on the percentage of the population of cells staining low
or high for Annexin V (apoptotic cells) and propidium
iodide (necrotic cells).Journal of Carcinogenesis 2004, 3:16 http://www.carcinogenesis.com/content/3/1/16
Page 4 of 13
(page number not for citation purposes)
Caspase Activity Assay
Activities of caspase-3 and -9 were determined using the
corresponding caspase activity detection kits (R&D Sys-
tems, Minneapolis, MN) as described previously [15].
Briefly, 100 µg of total protein was added to 50 µl of reac-
tion buffer, and 5 µl of substrates DEVD-pNA and LEDH-
pNA were used to analyze the activity of caspase-3 and -9
respectively. Samples were incubated at 37°C for 3 hours
and the enzyme-catalyzed release of pNA was quantified
at 405 nm using a microtiter plate reader. The values of
treated samples were normalized to corresponding
untreated controls allowing determination of the fold
increase or decrease in caspase activity. Alterations in
enzymatic activity directly attributable to NOX were deter-
mined by the change in caspase activity in the presence or
absence of 1 mM DTT.
Cell Viability Assay
Cell viability was determined via a modified MTT assay as
previously described [16]. In brief, cells were incubated
with the various NOX donors for 24 hours at 37°C prior
to cell viability assay. The media was aspirated and
replaced with 0.2 ml of MTT (1 mg/ml in PBS), followed
by incubation at 37°C for 5 hours. MTT was then aspi-
rated and the wells were air dried for 5 minutes. The crys-
tals were dissolved with 200 µl of DMSO, until the
solution turned purple and absorbance analyzed in an
enzyme-linked immunosorbent assay (ELISA) plate
reader at 540 nm.
Nitrotyrosine Staining
Pathologic nitric oxide exposure was confirmed by immu-
nostaining using an anti-nitrotyrosine (Upstate Biotech-
nology, Lake Placid, NY) monoclonal antibody by
immunoperoxidase as previously described [17]. The
nitrotoyrosine Mab have previously demonstrated specific
activity against human nitrotyrosine.
Statistical Analysis
Statistical evaluation was performed using Prism-3.00
(GraphPad Software Inc., San Diego, CA). A p-value of
<0.05 was considered significant. Values listed repre-
sented mean ± the standard error of the mean unless oth-
erwise indicated.
Results
Increasing Concentrations of NOX donors Increases 
Nitrosative Stress
Our first aim was to confirm that adding nitric oxide
donors into aqueous media increased NOX production in
a concentration dependent fashion. To investigate this, we
determined the accumulation of NO2
- in the supernatants
based on the Greiss reaction. Figure 1 demonstrates the
concentration of nitrite in media in the absence of and in
the presence of our two cell lines. In the absence of cells,
we demonstrated an increasing concentration of nitrite
within the media after 24 hours of incubation of various
concentrations of all four NOX donors. This increase in
nitrite accumulation was the same when NOX donors were
added to the media alone or to the supernatants of our
two cell lines. These data proved that our NOX donors
were liberating NOX  in a concentration dependent
fashion.
We then confirmed that the published half-lives of our
donor compounds were consistent with the kinetic release
of NOX in our system. Using λ maximum specific for each
donor compound, we found that the decay in absorbance
to half-maximum roughly reflected the published t1/2 for
each of our donor compounds [data not shown].
To confirm that our cell lines were indeed being exposed
to increasing amounts of NOX resulting from the addition
of our NOX donors, we examined immunostaining for
nitrotyrosine [Table 1]. In the absence of NOX donors,
both cell lines demonstrated low levels of nitrotyrosine
staining which increased with the addition of our donor
compounds. The addition of exogenous NOX increased
the staining intensity for nitrotyrosine in both cell lines,
which appeared to saturate at a moderate level of immu-
nostaining for nitrotyrosine. This result suggests ongoing
low level of autologous nitration, and confirms that cells
are being exposed to increasing nitrosative stress with the
addition of NOX donors.
DNA strand-breaks after exposure to NOX
In order to quantify the ability of exogenous NOX to cause
mutational events, we performed the in-vitro single-cell
gel electrophoresis assay (the COMET assay). Increasing
concentrations of these NOX donors were added to the
supernatants of our cell lines and DNA strand-breaks were
measured. As seen in Figure 2, distinctly different suscep-
tibility to NOX exposure was seen in WI38 when com-
pared to the tumor cell lines A549. Increasing
concentrations of NOX  donors increased DNA strand
breaks in a concentration dependent fashion in the lung
adenocarcinoma cell line, A549. Exposure of WI38 cells to
increasing concentrations of NOX  failed to cause an
increase in DNA fragmentation that was detectable by the
COMET assay. Examples of COMET tail moments seen in
untreated A549 cells, in cells exposed to low concentra-
tions, and high concentrations of NOX donors are seen in
Figure 3.
Determination of Cell Viability as a result of NOX-
dependent DNA Fragmentation
We then utilized the MTT assay to explore if this NOX-
donor compound induced DNA fragmentation caused a
decrease in cell viability. As demonstrated in Figure 4,
both cell lines were found to have a decrease in cellJournal of Carcinogenesis 2004, 3:16 http://www.carcinogenesis.com/content/3/1/16
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viability after exposure to increasing concentrations of
either thiol based or NONOate-based NOX donors. Our
control fibroblast cell line appeared to be more suscepti-
ble to NOX exposure, in that WI38 demonstrated a signif-
icant decrement in cell viability between 75 and 300 µM.
Interestingly, the NONOate-based NOX donors were able
to significantly decrease the cell viability of WI38 cells at
a lower concentration than the thiol-based NOX donors.
This is contrasted with our tumor cell line, A549. The dec-
rement in cell viability for A549 was not significant until
600 µM of these NOX donors. In fact, a significant increase
in cell growth was seen at the lowest concentration (75
µM) of SNAP in our A549 cells. Therefore, within the
range of concentrations of NOX donor compounds stud-
ied, we have found that NOX has the ability to induce
DNA fragmentation in A549 but not in the WI38 cells,
while significantly decrease cell viability for WI38 relative
to A549 cells.
Nitrite Production in Media and Supernatants in the Presence of Increasing Concentrations of NOX Donors Figure 1
Nitrite Production in Media and Supernatants in the Presence of Increasing Concentrations of NOX Donors: A. 
Nitrite production in media without cells, B. Nitrite production in WI38 supernatants, C. Nitrite production in A549 Superna-
tants. Measurements of nitrite production in media alone or the supernatant of WI38 and A549 as measured by the Greiss 
reaction demonstrate increasing concentrations of nitrite production in the presence of increasing concentrations of NOX 
donors. This confirms that our NOX donors are liberating NOX in a concentration-dependent fashion. Interestingly, the curves 
for SNAP and glycol-SNAP were shifted toward the right in the supernatants of both WI38 and A549 possibly reflecting the 
possibility that these thiol-based NOX donors were preferentially donating their NOX to intracellular thiols.
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Table 1: 
Cell Line Nitrotyrosine Staining (Intensity)
NO• Donor 
Concentration 
(µM)
Control SNAP Glyco-SNAP DETA Spermine
A549 0+
75 ++ + + ++
150 ++ ++ ++ ++
300 ++ ++ ++ ++
WI38 0+
7 5 ++ +++ +
1 5 0 + + ++ ++ +
300 ++ ++ ++ ++
Mean nitrotyrosine staining intensity per 100 cells: 0+-no staining, 1+-mild staining, 2+-moderate staining, 3+-intense staining.
COMET Tail Moment Lengths After 24 hour Exposure to Various NOX Donors Figure 2
COMET Tail Moment Lengths After 24 hour Exposure to Various NOX Donors: A. COMET tail moment of WI38 
after 24 hours of exposure to increasing concentrations of NOX, B. COMET tail moment of A549 after 24 hours of exposure 
to increasing concentrations of NOX. Measurements of the COMET tail moments for WI38 and A549 in the presence of 
increasing concentrations of NOX donors demonstrate that A549 was found to have increasing DNA strand breaks as nitrosa-
tive stress increased which was not seen in the WI38 control cell line. As seen in the graph, NOX donors with a long half-life 
[i.e. glyco-SNAP with a t1/2 = 28 hours and DETA-NONOate with a t1/2 of 20 hours] demonstrated significant increases in 
COMET tail moments only at the higher concentrations of NO donor, whereas NO donors with a shorter half-life [i.e. SNAP 
with a t1/2 of 10 hours and Spermine-NONOate with a t1/2 of 39 minutes] demonstrated significant increases in DNA strand 
breaks at lower concentrations. This confirms that A549 demonstrates more genomic instability in the presence of increasing 
nitrosative stress, which is not seen in control cells.
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Determination of apoptosis after exposure to NOX donors
We then sought to determine whether NOX-mediated
increases in DNA strand breaks correlated with apoptosis
via the TUNEL assay. Since a decrease in cell viability was
not seen until A549 cells were exposed to 600 µM NOX-
donor, we examined apoptosis after exposure to this con-
centration. Cultured cells were exposed to 600 µM of the
thiol-based NOX-donor, SNAP, or the NONO-ate based
NOX  donor, Spermine. Either NOX  donor compound
exposure for 24 hours did not significantly increase the
percentage of TUNEL positive cells when compared with
untreated controls [data not shown].
Because TUNEL positivity represents a late event in the
apoptotic cascade, we wanted to ensure that the assay time
frame did not represent assessment prior to detectable
apoptosis. Therefore, we confirmed our apoptosis results
via Annexin-V/propidium iodide FACS sorting. After
exposure of our cell lines to 600 µM of SNAP or Spermine-
NONOate, we confirmed the absence of any significant
increase in apoptosis (Figure 5).
Determination of caspase activity after NOX exposure or 
inhibition of NOX production
In an attempt to explain these seemingly contradictory
data, we examined the role of NOX in the modulation of
caspase enzyme function via an in vitro caspase activity
assay (figure 6). Using the artificial substrates DEVD-pNA
and LEDH-pNA for assaying caspase-3 and -9 activity
respectively, we demonstrated a basal inhibition of cas-
pase-3 in A549 cells as demonstrated by a significant
increase in caspase substrate cleavage with the addition of
the NOX-specific inhibitor, NΩ-monomethyl-L-arginine
(L-NMMA), when compared to control cells. This inhibi-
tion appears to be attributable to basal S-nitrosation of
caspase-3, since the addition of 1 mM DTT also
Example COMET Tail Moments for A549 Figure 3
Example COMET Tail Moments for A549: These are example COMET tail moments for A549 in the presence of A.) 0 
µM, B.) 75 µM, and C.) 150 µM Spermine-NONOate. Note that a significant increase in tail moment can be visualized with 
increasing concentrations of this NOX donor.
A.
B. C.Journal of Carcinogenesis 2004, 3:16 http://www.carcinogenesis.com/content/3/1/16
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significantly increased caspase-3 activity. With the addi-
tion of exogenous NOX via our thiol-based donor com-
pound, SNAP, a significant decrease in the activity of both
caspases was found. In contrast, our NONOate-based
NOX donor, Spermine, was unable to decrease either cas-
pase-3 or -9 activities. The inhibition of both caspase's
activity by SNAP was reversed with exposure to 1 mM
DTT, suggesting that transnitrosation of these caspase
enzymes may contribute to the inhibition of enzymatic
activity. These data suggest that thiol-based NOX-medi-
ated inhibition of caspase activity in A549 cells may cause
a relative tolerance to ongoing DNA damage by inhibiting
apoptosis.
Discussion
We have demonstrated that NOX genotoxicity is highly
dependent upon the concentration and kinetics of deliv-
ery of NOX. In addition, tumor cells appear to have
increased genomic instability but increased resistance to
ongoing NOX-mediated genotoxicity when compared to
more normal transformed cells which demonstrate less
genomic instability but increased susceptibility to ongo-
ing DNA damage. Moreover, the mechanism of NOX
delivery appears to have profound consequences upon the
function of downstream effector molecules such as
caspases.
Over the past 20–30 years key proteins have been increas-
ingly implicated as targets for nitric oxide signaling. With
respect to its role in cancer, both carcino-protective [18]
and carcinogenic roles [19] have been attributed to NOX.
The seemingly paradoxic nature of NOX in cancer has
made investigations in this area quite enigmatic.
Increasing evidence supports NOX's role in the induction
and promotion of cancer [8,20]. Chronic inflammatory
nitrosative stress has been implicated in carcinogenesis in
a number of other organ systems [21,22]. Within this lung
adenocarcinoma model, it is easy to hypothesize that
either endogenous chronic inflammatory nitrosative
stress as seen with idiopathic pulmonary fibrosis, or exog-
enous NOX as a result of cigarette smoking may predis-
pose individuals to the development of this type of cancer.
One mechanism by which NOX has been hypothesized to
be carcinogenic is through oxidative/nitrosative DNA
damage and genotoxicity [23-25]. NOX can induce muta-
tional events via DNA oxidation, deamination, point-
mutations, and strand-breaks, thus contributing to the
multi-step process of carcinogenesis. A number of papers
have documented that NOX can cause DNA strand breaks
in areas of chronic nitrosative stress [26-28]. Our data
demonstrates that in the human lung adenocarcinoma
Cell Viability as Determined by the MTT Assay with Exposure to Increasing Concentrations of NOX Donors Figure 4
Cell Viability as Determined by the MTT Assay with Exposure to Increasing Concentrations of NOX Donors: A. 
Cell viability of WI38 as measured by the MTT assay after exposure to increasing concentrations of NOX, B. Cell viability of 
A549 as measured by the MTT assay after exposure to increasing concentrations of NOX. The cell viability was significantly 
reduced in WI38 the presence of increasing concentrations of NOX donors at all concentrations greater than 150 µM (p < 
0.007 for all) for DETA- and spermine-NONOate, whereas the thiol-based glycol-SNAP and SNAP did not significantly 
decrease cell viability until 300 µM concentrations. These results are contrasted with A549 cells which did not demonstrate a 
significant decrease in cell viability (p < 0.03) until 600 µM concentrations of either thiol-based or NONOate-based NOX 
donors. Interestingly, the lowest concentration of SNAP (75 µM) demonstrated a significant growth advantage (p = 0.01).
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cell line, A549, increasing concentrations of NOX donors
increases DNA strand-breaks in a concentration depend-
ent fashion. Moreover, the kinetics of NOX exposure also
affects its genotoxicity. It is hypothesized that this ongo-
ing DNA damage can lead to cancer development. In
support of this notion, in a mouse model of inflammatory
mediated lung carcinogenesis, studies have demonstrated
that genetic ablation of the inducible isoform of nitric
oxide synthase decreased the lung tumor multiplicity after
exposure to the carcinogen, urethane [29].
The data presented herein of NOX-dependent DNA strand
breaks in A549 cells is in stark contrast to NOX's inability
to induce DNA fragmentation in our control fibroblast
cell line, WI38. Normally, DNA damage is repaired by a
complex series of DNA repair mechanisms. Defects in
repair mechanisms can predispose people to cancer devel-
opment [30]. An increasing body of evidence supports
epigenetic modulation of enzymatic function, such as S-
nitrosation [31]. As a result of nitrosation of key thiol
groups within DNA repair enzymes, DNA-damage repair
can be inhibited potentially perpetuating mutational
events. One possible explanation for these opposing sets
of data is that A549 may be capable of expressing unstim-
ulated NOS activity [32], and therefore may have
saturated such intracellular thiols as glutathione. In sup-
port of this hypothesis, immunostaining for nitrotyrosine
in both cell lines found low levels of nitrotyrosine
Annexin-V/Propidium Iodine FACS in A549 Cells Unexposed and Exposed to High Concentrations of NOX Donors Figure 5
Annexin-V/Propidium Iodine FACS in A549 Cells Unexposed and Exposed to High Concentrations of NOX 
Donors: A. Untreated control, B. 600 µM Spermine NONOate treated, C. 600 µM SNAP treated. Annexin-V/Propidium 
Iodine FACS confirms the TUNEL results that demonstrate that no significant increase in apoptosis is noted in A549 with or 
without exposure to high nitrosative stress.
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staining in the absence of exogenous NOX. Research is
ongoing to determine whether tumor elicited NOX pro-
duction may contribute to tumor progression.
If DNA damage overwhelms repair mechanisms, normal
cells are triggered to undergo apoptosis. Redundant mech-
anisms for the induction of apoptosis exist, but the most
common pathway involves the induction of p53. With the
induction of p53, apoptosis is triggered through the
release of cytochrome c and caspase activation. Despite
possessing wild-type p53, our data demonstrated that in
A549 cells we were unable to detect a decrease in cell via-
bility as measured by the MTT assay until very high con-
centrations of donors, or an increase in cell apoptosis via
either the TUNEL assay or Annexin V/propidium iodide
FACS. There are conflicting results in the literature regard-
ing the effects of exogenous NOX on cell viability and
apoptosis. Certain studies have shown that NOX by itself
does not cause A549 cells to die, but the addition of
hyperoxia induces rapid cell death [33], perhaps through
the production of peroxynitrite. On the other hand, other
studies have demonstrated that the addition of the NOX
donor SNAP decreased cell viability via apoptosis in a
concentration dependent fashion [34]. This study went on
to analyze apoptosis in cells other than A549, thus pre-
cluding a direct correlation with A549 and apoptosis after
SNAP exposure.
Further confusing the interrelationship between DNA
fragmentation and apoptosis is the fact that the prevailing
opinion in the literature is that there exists a direct corre-
lation between the fragmentation seen in the COMET
assay and the fragmentation seen in apoptosis. With trig-
gering of apoptosis, DNA strands are cleaved or nicked by
nucleases, exposing 3'-hydroxyl ends. Nick-end cleavage
may not necessarily equate with strand breaks seen with
various mutagens. A growing body of evidence suggests
that the fragmentation found in the COMET assay is not
necessarily related to apoptotic fragmentation [35,36].
Studies have demonstrated that COMET tail moments of
cells undergoing apoptosis are highly fragmented to the
point of loosing nuclear architecture [37]. Furthermore,
nitroso-compound related DNA damage appears to be
independent of more commonly accepted measures of
apoptosis, such as the TUNEL assay [38]. The mechanistic
basis for these disparate measures remains to be deter-
mined, but appears to represent fundamental differences
in the characteristics of exposed 3' ends seen with oxida-
tive DNA damage versus apoptosis related DNA cleavage.
Therefore, the COMET assay may be a measure of genoto-
xicity, without necessarily detecting apoptosis.
Lending credence to NOX's possible carcinogenic role is
the implication from several lines of study that NOX can
influence enzymatic function of such enzymes as caspases
[11]. In this way, NOX may increase the threshold by
which cells that have undergone a level of genotoxicity
would be triggered to undergo apoptosis. If any member
of the apoptotic pathway is lost or inhibited, the thresh-
old for apoptosis would theoretically be increased. NOX
has demonstrated a capability of inhibiting caspase activ-
ity through S-nitrosation of key thiols [15,39]. Our data
supports the NOX-mediated inhibition of both caspase-3
and -9 in A549 cells with ongoing DNA mutational
events. In fact, prior data has demonstrated that basal
inhibition of mitochondrial caspases by cysteine
nitrosation must be removed in order to activate the cas-
pase-mediated apoptotic pathways [40]. Our data
supports this in A549 in that the addition of the antioxi-
dant, DTT, increased caspase activity detectable by our in
fluorogenic assay. One potential mechanism for this inhi-
bition of casapase activity is the S-nitrosation of essential
thiol groups [40]. The fact that our thiol-based NOX donor
appeared to inhibit caspase activity more efficiently that
the NONOate donor further supports this notion, since it
is well known that nitroso-thiols will preferentially tran-
snitrosate other thiols [41]. In light of the increasing inter-
est in NOX-donor compounds as cytotoxic cancer therapy,
a careful consideration of potential downstream effects of
the mode of NOX delivery should be undertaken. Cas-
pases can be inhibited not only by direct protein S-nitro-
sation, but also indirectly by a cGMP-mediated pathways
[39]. The return of caspase activity with the addition of
DTT would further suggest that caspase inactivation was
mediated by S-nitrosation in our lung adenocarcinoma
model.
The implications of these data can be applied both to the
understanding of tumor progression as well as the design
of NOX-based chemotherapeutic strategies. It is well estab-
lished that tumors demonstrate a high rate of cellular
turnover, with the vast majority of cells undergoing cell
death resulting from ongoing genomic instability. Only
those clones possessing a survival advantage will be able
to repopulate the tumor and thus contribute to increasing
aggressiveness, the ability to invade and metastasize, and
resistance to further therapeutic interventions. Chronic
nitrosative stress may be contributing to this process by
selecting for more virulent clones via inducing DNA
mutational events and perpetuating these mutations
through a relative inhibition of apoptosis. Moreover, as
more investigations explore the potential use of NOX
delivery as a possible cytotoxic chemotherapy, the issues
of concentration, kinetics, and mechanism of delivery
must be carefully considered in order to avoid untoward
pro-carcinogenic side effects.
Conclusions
In conclusion, we demonstrate that tumor cells experience
an increase in DNA strand breaks with increasingJournal of Carcinogenesis 2004, 3:16 http://www.carcinogenesis.com/content/3/1/16
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Caspase 3 (DEVD-pNa) and Caspase 9 (LEDH-pNa) Activity as Measured by the in vitro Fluorogenic Caspase Assay in the  Absence and Presence of High Concentrations of NOX Donors Figure 6
Caspase 3 (DEVD-pNa) and Caspase 9 (LEDH-pNa) Activity as Measured by the in vitro Fluorogenic Caspase 
Assay in the Absence and Presence of High Concentrations of NOX Donors: Both endogenous and exogenous NOX 
appears to influence caspase activity in A549 cells. Caspase 3 activity appears to demonstrate endogenous NOX inhibition since 
the addition of 3 mM L-NMMA or 1 mM DTT significantly increased caspase 3 activity (p = 0.001, p = 0.003 respectively). No 
similar endogenous inhibition was seen with caspase 9. The addition of the thiol-based NOX donor, SNAP (600 µM), signifi-
cantly inhibited both caspase 3 and caspase 9 (p < 0.001 for both) when compared with control cell caspase activity. This cas-
pase activity was significantly reversed with the addition of DTT (p < 0.001 for both caspase 3 and 9). Treatment groups: 1) 
Control, 2) 3 mM L-NMMA, 3) 1 mM DTT, 4) 600 µM Spermine-NONOate, 5) 600 µM SNAP, 6) 600 µM SNAP + 1 mM DTT.
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nitrosative stress relative to the concentration and kinetics
of delivery. This nitrosative stress does not correlate with
increased cell death or apoptosis in established tumor cell
lines, which is in stark contrast to non-tumor
immortalized cells. The lack of apoptosis associated with
increased DNA fragmentation may in part be explained by
the inhibition of caspase-3 and -9 activity by thiol-based
delivery but not NONOate-based delivery of NOX. Taken
together, these data support the role of NOX in nitrosative
genomic instability as well as inhibiting apoptosis, impli-
cating it in cancer promotion. The demonstration of these
same findings in rodent cell lines would establish the
foundation for animal models with which to fully eluci-
date the role of NOX in tumor development and growth.
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